IgA Nephropathy: Are We There Yet?

November 20, 2016 | 10:00 AM - 12:00 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

Add to Outlook Calendar Add to Google Calendar Add to Yahoo! Calendar Add to iCal Calendar

Translational Session

IgA Nephropathy: Are We There Yet?

November 20, 2016 | 10:00 AM - 12:00 PM

Location: W185

Session Description

IgAN is the most prevalent glomerulonephritis worldwide. This session updates the Oxford classification and elaborates on the status on IgA pathophysiology and the genetic risk factors and emerging treatment strategies.

Session Objectives

Upon completion of this session, the participant will be able to: 1. explain the value of the renal biopsy in evaluating IgAN patients; 2. describe the pathophysiology of IgA in IgAN; 3. discuss genetic risk factors and how they give insight into the mechanisms of IgAN; and 4. apply useful treatment strategies based on emerging clinical trials.

Learning Pathways

  • Glomerular Diseases
  • Pathology

Moderators

  • Robert B. Colvin, MD
  • Mark Haas, MD, PhD

Lectures

Genetic Risk Factors and Mechanisms Add to your Outlook, Google, Yahoo, or Apple iCal Calendar
10:00 AM - 10:30 AM
Krzysztof Kiryluk, MD

IgA Pathophysiology and Abnormal Glycosylation Add to your Outlook, Google, Yahoo, or Apple iCal Calendar
10:30 AM - 11:00 AM
Jan Novak, PhD

Update on the Oxford Classification Add to your Outlook, Google, Yahoo, or Apple iCal Calendar
11:00 AM - 11:30 AM
Ian Roberts, MBChB

Emerging Therapeutic Strategies in IgAN Add to your Outlook, Google, Yahoo, or Apple iCal Calendar
11:30 AM - 12:00 PM
Jürgen Floege, MD